![]() PMV Pharma PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. | |||
Founding Date | Founding Date 2012 | Founding Date 1997 | Founding Date 2013 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ | Locations Galway, IE HQ Ratingen, DE New Delhi, IN Dubai, AE Chicago, US San Mateo, US | Locations Cranbury Township, US HQ |
Employees | Employees 244% decrease | Employees 6033% increase | Employees 642% increase |
Funding | |||
Latest funding round | Latest funding round $ 25m (over 10 years ago) | Latest funding round $ 33.9m (about 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 36m | Total funding raised $ 33.9m | Total funding raised $ 236m |

Aerogen is an innovative medical device and drug delivery company.
View company
PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.
View company